This bill mandates the Commissioner of Health to create a program within the Department of Health aimed at purchasing and distributing xylazine test strips to entities that provide authorized harm reduction services in New Jersey. The program will involve overseeing the bulk purchasing and distribution of these test strips upon request from the entities, as well as establishing and maintaining a public website that offers information about xylazine test strips and their availability through these services.

Additionally, the bill includes an appropriation from the General Fund to the Department of Health for the necessary funds to implement the program. The Commissioner of Health is also granted the authority to adopt any necessary rules and regulations to ensure the effective execution of the bill's provisions. The act is set to take effect immediately upon passage.